# Study to Evaluate the Efficacy and Safety of Different Doses of Graminidin With Anesthetic, a Metered Dose Topical Spray, in the Treatment of Acute Infectious and Inflammatory Pharyngeal Diseases Compared With Drug Septolete Total, Lozenges

> **NCT06843018** · PHASE2 · RECRUITING · sponsor: **Valenta Pharm JSC** · enrollment: 300 (estimated)

## Conditions studied

- Pharyngitis Acute
- Pharyngitis
- Nasopharyngitis
- Exacerbation of Chronic Pharyngitis

## Interventions

- **DRUG:** Grammidin with anesthetic
- **DRUG:** Septolete Total

## Key facts

- **NCT ID:** NCT06843018
- **Lead sponsor:** Valenta Pharm JSC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-14
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06843018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06843018, "Study to Evaluate the Efficacy and Safety of Different Doses of Graminidin With Anesthetic, a Metered Dose Topical Spray, in the Treatment of Acute Infectious and Inflammatory Pharyngeal Diseases Compared With Drug Septolete Total, Lozenges". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06843018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*